Process for treating contact dermatitis

a technology for contact dermatitis and skin eruptions, applied in the field of contact dermatitis compositions, can solve the problems of irritation, irritation, dry, stiff skin, blistering, erosion, etc., and achieve the effect of rapid drying and easy application to the skin

Inactive Publication Date: 2005-09-01
MCCADDEN MICHAEL E
View PDF8 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0011] Among the objects of the present invention, therefore, is the provision of a composition for topical treatment of rashes, dermatoses and skin eruptions, the provision of such a composition which is easily applied to the skin, the provision of such a composition which contains a corticosteroid of the appropriate potency for the condition being treated, the provision of such a composition which promotes rapid drying of moist areas and coats the skin with the drying agent for protection and healing, especially moist exudative rashes and / or rashes in moist areas.

Problems solved by technology

Irritants will cause an inelastic and stiff-feeling skin, discomfort due to dryness, pruritus secondary to inflammation, and pain due to fissures, blisters, and ulcers.
Chronic exposure to mild irritants or allergens results in dry, thickened, and fissured skin.
Strong irritants cause blistering, erosion, and ulcers of the skin.
If involvement is severe there may be marked edema, particularly of the face and in the periorbital and genital areas.
Individually these therapies do not bring rapid relief of all the symptoms of pruritus (itch), the inflammation of the dermatitis, as well as vesiculation and oozing.
But when used alone they typically do not provide relief from the inflammation caused by the dermatitis.
None of the above agents provide rapid drying of a moist, oozing rash while helping to absorb further moisture and keep the skin dry, and at the same time treat the contact dermatitis.
All of these conditions can present with a rash that can become moist, weeping, and quite irritated.
The rashes can also become secondarily infected.
Current therapeutic options do not always clear these conditions as rapidly as desired.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0014] The composition of the present invention may be in the form of a solution, spray, lotion, cream, gel or ointment. The preferred form of the composition depends upon the condition being treated and the desired therapeutic effect. For example, treatment of a moist, acutely inflamed rash is preferably treated with a lotion, whereas treatment of a chronic dry patch is often treated more effectively with a cream or ointment. In general, the effectiveness of the composition is directly related to the form of the composition with ointment forms of corticosteroid being stronger than gels, gels being stronger than creams, creams being stronger than lotions and solutions. For example, ointment preparations of the same corticosteroid in the same concentration are generally stronger than the cream preparation.

[0015] The lotions of the present invention include liquid suspensions and dispersions. Solid-in-liquid suspensions are preparations of finely divided, undissolved drugs or other p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
weight percentaaaaaaaaaa
weight percentaaaaaaaaaa
wt %aaaaaaaaaa
Login to view more

Abstract

Composition for topical administration comprising (a) a corticosteroid, and (b) a drying agent.

Description

REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation of Ser. No. 10 / 292,251, filed Nov. 12, 2002 which is a continuation of Ser. No. 09 / 652,811, filed Aug. 31, 2000, now U.S. Pat. No. 6,479,058 which claims the benefit of provisional application Ser. No. 60 / 152,068, filed Sep. 2, 1999.BACKGROUND OF THE INVENTION [0002] The present invention relates to a composition for the treatment of rashes, dermatoses or skin eruptions, which are known to be treated topically to improve or favorably alter the disease condition. Such rashes, dermatoses or skin eruptions include acute, inflammatory reactions of the skin caused by an allergic or irritant reaction (such as that caused by poison ivy, poison oak or poison sumac, or other forms of allergic or irritant contact dermatitis), other forms of eczema, lichen simplex chronicus, rashes, dermatoses or skin eruptions of a chronic nature (e.g. seborrheic dermatitis, psoriasis, atopic dermatitis) or caused by infection, irrita...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K8/19A61K8/27A61K8/63A61K9/00A61K47/02A61K47/10A61Q17/00A61Q19/00
CPCA61K8/19A61K8/27A61K8/63A61K9/0014Y10S514/862A61K47/10A61Q17/00A61Q19/00Y10S514/871A61K47/02
Inventor MCCADDEN, MICHAEL E.
Owner MCCADDEN MICHAEL E
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products